Indications
Therapeutic Asset Ratings
13,150 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Colchicinum
Obesity Disorder
Donders Centre for Cognitive Neuroimaging
P2
CCC
(55)
Conestat Alfa
Acute Kidney Injury
University Hospital, Basel, Switzerland
P2
CCC
(55)
cpl500036 - high dose
Drug-Induced Dyskinesia
Celon Pharma SA
P2
CCC
(55)
cpl500036 - low dose
Drug-Induced Dyskinesia
Celon Pharma SA
P2
CCC
(55)
Crizotinib
Metastatic Malignant Neoplasm
M.D. Anderson Cancer Center
P2
CCC
(55)
Cyclophosphamide
Autoimmune Hemolytic Anemia
City of Hope Medical Center
P2
CCC
(55)
Cyclophosphamide
Therapy-Related Myeloid Neoplasm
M.D. Anderson Cancer Center
P2
CCC
(55)
Cyclophosphamide
Hemophagocytic Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(55)
Cyclophosphamide
Langerhans Cell Histiocytosis
M.D. Anderson Cancer Center
P2
CCC
(55)
Cyclophosphamide
Liver Cancer
Shanghai Zhongshan Hospital
P2
CCC
(55)
Cyclophosphamide
X-Linked Lymphoproliferative Syndrome
Masonic Cancer Center, University of Minnesota
P2
CCC
(55)
Cyclosporin A
Lymphoplasmacytic Lymphoma
Fred Hutchinson Cancer Center
P2
CCC
(55)
Cytarabine
Mixed Phenotype Acute Leukemia,T/Myeloid
yuejun Liu
P2
CCC
(55)
Dabrafenib
Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
P2
CCC
(55)
Dabrafenib
Colorectal Cancer
Tianjin Medical University Cancer Institute and Hospital
P2
CCC
(55)
Danuglipron
Obesity Disorder
Pfizer
P2
CCC
(55)
Dapagliflozin
Depressive Disorder
Tanta University
P2
CCC
(55)
Daratumumab
Non-Small Cell Lung Carcinoma
Georgetown University
P2
CCC
(55)
Daratumumab
Lymphoma
M.D. Anderson Cancer Center
P2
CCC
(55)
Daridorexant
Cognitive Disorder
University of Rochester
P2
CCC
(55)
Daridorexant
Delirium
University of Rochester
P2
CCC
(55)
Darolutamide
Triple-Negative Breast Carcinoma
Vandana Abramson
P2
CCC
(55)
Dasatinib
B-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P2
CCC
(55)
Dasatinib
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P2
CCC
(55)
Dasatinib
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)
P2
CCC
(55)
Showing 2701 to 2725 of 13,150 assets
Previous
Page 109 of 526
Next